Page last updated: 2024-12-05

2,3,5-triiodobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3,5-Triiodobenzoic acid (TIBA) is a synthetic, non-herbicidal plant growth regulator that inhibits auxin transport. It is primarily used in research to study auxin transport and its role in plant development. TIBA acts by binding to the auxin efflux carrier protein PIN1, preventing the transport of auxin out of cells. This disruption of auxin transport can lead to various effects on plant development, including changes in root growth, stem elongation, and leaf morphology. TIBA has been used in a variety of studies investigating auxin transport and its role in plant responses to stress, including drought, salinity, and nutrient deficiency. TIBA is also used in research on plant development and its applications in agriculture. '
```

2,3,5-triiodobenzoic acid: inhibitor of auxin transport; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,3,5-triiodobenzoic acid : A member of the class of benzoic acids that is benzoic acid in which the hydrogens at positions 2, 3 and 5 are replaced by iodine atoms. It is an auxin polar transport inhibitor. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6948
CHEMBL ID115079
CHEBI ID73175
SCHEMBL ID39041
MeSH IDM0150186

Synonyms (71)

Synonym
AC-17003
BB 0245940
tib
johnkolor
floraltone
triiodobenzoic acid
2,5-tiba
regim 8
88-82-4
2,5-triiodobenzoic acid
nsc2582
regin 8
wln: qvr bi ci ei
nsc-2582
tiba
benzoic acid,3,5-triiodo-
benzoic acid, 2,3,5-triiodo-
a 20812
ai3-27442
2,3,5-tiba
kyselina 2,3,5-trijodbenzoova [czech]
nsc 2582
epa pesticide chemical code 009104
einecs 201-859-6
triiodobenzoic acid (van)
brn 1955088
caswell no. 890a
2,3,5-triiodobenzoic acid
inchi=1/c7h3i3o2/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2h,(h,11,12
2,3,5-triiodobenzoic acid, bioreagent, plant cell culture tested, >=97% (hplc)
B3I ,
2,3,5-triiodobenzoic acid, 98%
STK390176
AKOS000109232
2,3,5-triiodo-benzoic acid
CHEMBL115079
chebi:73175 ,
T0451
BBL014157
NCGC00248208-01
kyselina 2,3,5-trijodbenzoova
unii-h575a4059q
h575a4059q ,
hsdb 7575
tox21_300914
NCGC00254818-01
cas-88-82-4
dtxcid2021317
dtxsid4041317 ,
2,3,5-tri-iodobenzoic acid
c7h3i3o2
acide 2,3,5-triiodobenzoique
FT-0609456
AM20041296
AB01330639-02
SCHEMBL39041
2,3,5-triiodobenzoic acid [hsdb]
a-20812
regim 8 (salt/mix)
W-100387
mfcd00002420
2,3,5-triiodobenzoic acid, technical grade
CS-W011500
SY036835
DS-18053
Q27105007
NCGC00248208-02
CK2209
EN300-20907
HY-W010784
Z104484766

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Results showed that TIBA caused a significant decrease in serum AST activity with both the dosage whereas serum CPK was significantly increased with 100 ppm dosage of TIBA."( Influence of subacute treatment of some plant growth regulators on serum marker enzymes and erythrocyte and tissue antioxidant defense and lipid peroxidation in rats.
Celik, I; Isik, I; Tuluce, Y, 2006
)
0.33
" According to the results, MDA concentration significantly increased in the tissues treated with 100 ppm dosage of NAA or 2,4-D without any change in the tissues of rats treated with both dosage of TIBA."( Determination of toxicity of subacute treatment of some plant growth regulators on rats.
Celik, I; Tuluce, Y, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antiauxinsnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organoiodine compoundAn organoiodine compound is a compound containing at least one carbon-iodine bond.
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency66.44170.000221.22318,912.5098AID743036
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency1.47500.001530.607315,848.9004AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency66.44170.000229.305416,493.5996AID743075
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency15.37680.001019.414170.9645AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency18.72580.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency18.56900.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency0.527819.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency71.85680.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency65.88520.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID28691log LD50 was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (8.43)18.7374
1990's5 (6.02)18.2507
2000's32 (38.55)29.6817
2010's32 (38.55)24.3611
2020's7 (8.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.37 (24.57)
Research Supply Index4.44 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index34.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.19%)4.05%
Observational0 (0.00%)0.25%
Other83 (98.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]